MUSTANG BIO, INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2015 to Q4 2023

Taxonomy & unit
us-gaap: EUR and USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Mustang Bio, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2015 to Q4 2023.
  • Mustang Bio, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $148M, a 15.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $148M +$19.6M +15.3% Dec 31, 2023 10-K 2024-03-11
Q4 2022 $128M +$33.4M +35.2% Dec 31, 2022 10-K 2024-03-11
Q4 2021 $94.8M +$27.7M +41.3% Dec 31, 2021 10-K 2023-03-30
Q4 2020 $67.1M +$24.5M +57.4% Dec 31, 2020 10-K 2022-03-23
Q4 2019 $42.6M +$19.3M +82.5% Dec 31, 2019 10-K 2021-03-24
Q4 2018 $23.3M +$8.73M +59.8% Dec 31, 2018 10-K 2020-03-16
Q4 2017 $14.6M +$6.98M +91.4% Dec 31, 2017 10-K 2019-03-18
Q4 2016 $7.64M +$5.89M +337% Dec 31, 2016 10-K 2018-03-29
Q4 2015 $1.75M Dec 31, 2015 10-K 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.